Johnson & Johnson Legend Biotech Corp Transaction History
Johnson & Johnson
- $314 Million
- Q3 2024
A detailed history of Johnson & Johnson transactions in Legend Biotech Corp stock. As of the latest transaction made, Johnson & Johnson holds 814,586 shares of LEGN stock, worth $32.7 Million. This represents 12.65% of its overall portfolio holdings.
Number of Shares
814,586
Previous 814,586
-0.0%
Holding current value
$32.7 Million
Previous $36.1 Million
10.02%
% of portfolio
12.65%
Previous 12.46%
Shares
2 transactions
Others Institutions Holding LEGN
# of Institutions
225Shares Held
74.3MCall Options Held
279KPut Options Held
350K-
Price T Rowe Associates Inc Baltimore, MD11.2MShares$448 Million0.06% of portfolio
-
Ra Capital Management, L.P. Boston, MA7.51MShares$301 Million5.1% of portfolio
-
Hhlr Advisors, Ltd. Grand Cayman, E96.64MShares$266 Million7.41% of portfolio
-
Black Rock Inc. New York, NY5.72MShares$230 Million0.01% of portfolio
-
Westfield Capital Management CO LP Boston, MA5.04MShares$202 Million1.16% of portfolio
About Legend Biotech Corp
- Ticker LEGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 167,403,008
- Market Cap $6.72B
- Description
- Legend Biotech Corporation, a clinical-stage biopharmaceutical company, through its subsidiaries, engages in the discovery and development of novel cell therapies for oncology and other indications in the United States, China, and internationally. Its lead product candidate, LCAR- B38M, is a chimeric antigen receptor for the treatment of multipl...